Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines
- 14 November 2009
- journal article
- research article
- Published by Springer Nature in International Journal of Hematology
- Vol. 90 (5) , 545-552
Abstract
Overproduction of hepcidin by interleukin-6 (IL-6) is considered to be the main factor responsible for the development of anemia in inflammatory conditions. Since oncostatin M (OSM), a member of the IL-6 family, plays an important role in immune and inflammatory responses, we assessed the effect of OSM on hepcidin expression, as well as that of leukemia inhibitory factor (LIF), another member of the IL-6 family. We found that hepcidin expression was markedly induced by OSM and LIF in a time- and dose-dependent manner in hepatoma cell lines, and this expression was induced independent of IL-6/IL-6 receptor signaling. Luciferase assay revealed that OSM and LIF stimulated a −1.3-kb hepcidin promoter. This effect was markedly reduced when the signal transducer and activator of transcription (STAT) site of the promoter was mutated, and was almost completely abolished in the presence of AG-490, a Janus kinase (JAK) inhibitor. Hence, the JAK/STAT pathway plays a major role in OSM- and LIF-induced activation of the hepcidin promoter. In conclusion, we demonstrated that OSM and LIF can induce hepcidin expression mainly through the JAK/STAT pathways. Further studies are warranted to evaluate the clinical significance of OSM and LIF in the development of anemia in various inflammatory diseases.Keywords
This publication has 46 references indexed in Scilit:
- A Novel Immunological Assay for Hepcidin Quantification in Human SerumPLOS ONE, 2009
- Forging a field: the golden age of iron biologyBlood, 2008
- Body iron metabolism and pathophysiology of iron overloadInternational Journal of Hematology, 2008
- Withholding iron as a cellular defence mechanism – friend or foe?European Journal of Immunology, 2008
- Iron storage disease: Facts, fiction and progressBlood Cells, Molecules, and Diseases, 2007
- Interleukin-6 induces hepcidin expression through STAT3Blood, 2006
- Expression of oncostatin M and its receptors in normal and cirrhotic human liverJournal of Hepatology, 2005
- Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout miceHepatology, 2004
- Concentrations of serum leukemia inhibitory factor (LIF) in patients with hematologic malignancesLeukemia, 1997
- The acute phase responseImmunology Today, 1994